key: cord-0811105-6vo5xjcd authors: Goel, Divya; Kumar, Sudhir title: Co-morbid conditions in COVID-19 patients in Uttarakhand state of India date: 2021-02-15 journal: Journal of global health DOI: 10.7189/jogh.11.03029 sha: 519d7737c951dc8c2162118352fbc30af1e775cb doc_id: 811105 cord_uid: 6vo5xjcd nan Diabetes: Diabetes has been identified as one of the leading cause for mortality in COVID-19 patients [2] . People with type 1 or type 2 diabetes have other associated medical conditions like hyperglycemia, weak immune system along with hypertension and cardiovascular diseases that makes them more vulnerable [3] . In India as well, diabetes continues to be leading co-morbid condition. Data analysis from the state of Uttarakhand till 2 October 2020 show that out of 636 reported deaths due to COVID-19, 65 people (10.2%) had either Type 1 or type 2 diabetes (www.health.uk.gov. in). Out of these 5 had developed diabetic ketoacidosis and 2 had diabetic nephropathy. Data suggests that both male and females with underlying diabetic condition and having average age above 60 are at heightened risk to COVID-19 related mortality. Centre for disease prevention and control (CDC) recommend continuing the medications and keep track of the blood glucose for people with diabetes [2] . Kidney disease: Kidney disease like chronic kidney disease and acute kidney injury (AKI) are associated with the increased risk of the severe COVID-19 condition leading to mortality [2, 4] . A study conducted in China reported a 27% incidence of AKI in 85 COVID-19-positive patients with an increased risk associated with people above the age of 60 years suffering from hypertension, and coronary artery disease [5] . We have found 22 deaths with chronic kidney disease as comorbid condition in Uttarakhand state. A huge number of 62 deaths were reported as having acute kidney injury. Kidney diseases thus present a major challenge during the treatment of COVID-19. Hypertension: People with hypertension have also been recognized as high risk group in COVID-19 infection [2] . In some reports, hypertension has been reported in as much as 30% of the COVID-19 cases [6] . Elderly people have many age related conditions and hypertension is one of them, making it a common co-morbid condition. In Uttarakhand, 26 instances were found where hypertension was mentioned in cause of death out of 636 COVID-19 related death cases (4.1%). Hypertension can also be the indication of other cardio vascular condition or diabetes, and thus increase the change of progression of COVID-19 infection to severe category. Cancer: Cancer is generally considered a life threatening disease and the associated medical treatments like chemotherapy and radiotherapy tends to weaken the immune system of the body. A study done in China estimated that COVID-19 infected cancer patients are at 3.5 times larger risk of acquiring severe disease than other patients [7] . In Uttarakhand, we found that out of 636 reported deaths until 2 October 2020, 13 have cancer of varying stages. 6 had malignant form of the cancer with metastasis to other organs, while 4 have the lung carcinoma. Other type of cancers reported include 2 cases of oesophagal carcinoma, 2 cases of acute lymphoblastic leukemia, one case each of urinary bladder carcinoma and malignant mesothalioma. Pre-existing cardiovascular disease tends to increase the mortality rate in COVID-19 patients. COVID-19 infection can also cause problems in cardiovascular system like irregular heart beat (arrhythmia), myocardial injury, acute coronary syndrome and obstruction of a blood vessel by a blood clot (thromboembolism) [8] . We found 32 cases of coronary artery disease (CAD) among the 636 reported deaths in Uttarakhand. Several other cases listed cardiomyopathy as underlying cause. Other co-morbid conditions: Conditions such as COPD (chronic obstructive pulmonary disease), HIV, asthma etc have been listed as co-morbid conditions that can aggravate the COVID-19 infection [2] . We found 2 cases of HIV, 2 of asthma and 3 with COPD among the expired patients. In Uttarakhand, first COVID-19 death was reported on 1 May 2020. Maximum deaths are reported in age groups of 51-70 years contributing to 44% of total deaths from 1 May 2020 to 2 October 2020. Out of total deaths reported on 2 October 2020; 187 (30%) are female and 437 (70%) are male. Out of 187 deceased females, 74 (39.6%) were of age 50 years or less which is a worrying trend while only 30.6% deceased males were of same age group (Figure 1 ). Co-morbid conditions increase the risk of severe COVID-19 disease and also lead to increase in mortality among the patients. There is an urgent need to identify such conditions and their management. Due to COVID-19 pandemic, many of the patients already suffering from these diseases are being neglected while the diagnosis of new patients is also hampered severely. It is very important that these patients are diagnosed early and given adequate treatment. Another major worry for Uttarakhand state is the high rate of mortality among younger women (age <50 years). India has a large population and relatively less health facilities especially in states like Uttarakhand which has a challenging geographical area. Gradual increase in health facilities across state to ensure their reach to each and every person in the remotest of areas is the only way out of this pandemic. In comparison to males, younger females (age <50 years) had more cases of mortality due to Covid-19 in Uttarakhand which hints at the negligence of female health in state. Health bulletin Covid-19 update for Uttarakhand dated 22nd COVID-19): People with Certain Medical Condition Diabetes and COVID-19: Global and Regional Perspectives Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection Kidney diseases in the time of COVID-19: major challenges to patient care Hypertension and COVID-19 Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Sudhir Kumar Department of Biotechnology Hemvati Nandan Bahuguna Garhwal University Srinagar (Garhwal) Uttarakhand India-246174 sudhir Authorship contributions: DG collected the data and analyzed it. SK conceptualized and wrote the manuscript. The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.